SARS-CoV-2 seroepidemiology in paediatric population during Delta and Omicron predominance.


Journal

Epidemiology and infection
ISSN: 1469-4409
Titre abrégé: Epidemiol Infect
Pays: England
ID NLM: 8703737

Informations de publication

Date de publication:
19 10 2022
Historique:
entrez: 8 11 2022
pubmed: 9 11 2022
medline: 10 11 2022
Statut: epublish

Résumé

Limited prospective severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) data in children regarding the impact of Omicron variant in seropositivity have been reported. We investigated SARS-CoV-2 seropositivity in children between 1 September 2021 and 30 April 2022, representing Delta and Omicron predominance periods. Serum samples from children admitted to the major tertiary Greek paediatric hospital for any cause, except for COVID-19, were randomly collected and tested for SARS-CoV-2 natural infection antibodies against nucleocapsid antigen (Elecsys® Anti-SARS-CoV-2 reagent). A total of 506/1312 (38.6%) seropositive children (0-16 years) were detected (males: 261/506(51.6%); median age (IQR): 95.2 months(24-144)). Seropositivity rates (%) increased from Delta to Omicron period from 29.7% to 48.5% (

Identifiants

pubmed: 36345855
doi: 10.1017/S0950268822001601
pii: S0950268822001601
pmc: PMC9671918
doi:

Substances chimiques

Antibodies, Viral 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e177

Références

Public Health Pract (Oxf). 2020 Nov;1:100013
pubmed: 34171042
PLoS One. 2022 Mar 14;17(3):e0263679
pubmed: 35286328
Front Immunol. 2022 May 17;13:882456
pubmed: 35663948
Lancet Child Adolesc Health. 2022 Jun;6(6):384-392
pubmed: 35358491
BMJ Open. 2021 Jul 7;11(7):e053036
pubmed: 34234001
Eur J Clin Microbiol Infect Dis. 2022 Jun;41(6):997-999
pubmed: 35484359
J Med Virol. 2022 May;94(5):2174-2180
pubmed: 35064572
Epidemiol Infect. 2021 Nov 04;149:e237
pubmed: 34732275
Clin Chem Lab Med. 2022 Feb 25;60(6):941-951
pubmed: 35218170
MMWR Morb Mortal Wkly Rep. 2022 Apr 29;71(17):606-608
pubmed: 35482574
JAMA. 2022 Apr 26;327(16):1610-1611
pubmed: 35254379
JAMA Pediatr. 2021 Oct 1;175(10):e212025
pubmed: 34115094
Am J Obstet Gynecol. 2021 Jul;225(1):73.e1-73.e7
pubmed: 33497654
Science. 2022 May 6;376(6593):eabn4947
pubmed: 35289632
MMWR Morb Mortal Wkly Rep. 2021 Jan 22;70(3):88-94
pubmed: 33476314

Auteurs

Filippos Filippatos (F)

First Department of Pediatrics, Infectious Diseases and Chemotherapy Research Laboratory, Medical School, National and Kapodistrian University of Athens, "Aghia Sophia" Children's Hospital, Athens, Greece.

Elizabeth-Barbara Tatsi (EB)

University Research Institute of Maternal and Child Health and Precision Medicine, Athens, Greece.

Charilaos Dellis (C)

First Department of Pediatrics, Infectious Diseases and Chemotherapy Research Laboratory, Medical School, National and Kapodistrian University of Athens, "Aghia Sophia" Children's Hospital, Athens, Greece.

Dimitra-Maria Koukou (DM)

First Department of Pediatrics, Infectious Diseases and Chemotherapy Research Laboratory, Medical School, National and Kapodistrian University of Athens, "Aghia Sophia" Children's Hospital, Athens, Greece.

Christos Papagiannopoulos (C)

First Department of Pediatrics, Medical School, National and Kapodistrian University of Athens, "Aghia Sophia" Children's Hospital, Athens, 11527, Greece.

Alexandra Margeli (A)

Department of Clinical Biochemistry, "Aghia Sophia" Children's Hospital, Athens, Greece.

Tania Siahanidou (T)

First Department of Pediatrics, Medical School, National and Kapodistrian University of Athens, "Aghia Sophia" Children's Hospital, Athens, 11527, Greece.

Christina Kanaka-Gantenbein (C)

First Department of Pediatrics, Medical School, National and Kapodistrian University of Athens, "Aghia Sophia" Children's Hospital, Athens, 11527, Greece.

Vasiliki Syriopoulou (V)

First Department of Pediatrics, Infectious Diseases and Chemotherapy Research Laboratory, Medical School, National and Kapodistrian University of Athens, "Aghia Sophia" Children's Hospital, Athens, Greece.

Athanasios Michos (A)

First Department of Pediatrics, Infectious Diseases and Chemotherapy Research Laboratory, Medical School, National and Kapodistrian University of Athens, "Aghia Sophia" Children's Hospital, Athens, Greece.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH